<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-13 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-13</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-13</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-1.html">extraction-schema-1</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of age-specific poliovirus transmission, immunity, vaccination coverage, and infection patterns in Pakistan, with particular attention to the role of older age groups (older children, adolescents, and adults).</div>
                <p><strong>Paper ID:</strong> paper-2b2c1f5ac5099b382c377fe97bf082ea03b0be0a</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/2b2c1f5ac5099b382c377fe97bf082ea03b0be0a" target="_blank">Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan</a></p>
                <p><strong>Paper Venue:</strong> Vaccine: X</p>
                <p><strong>Paper TL;DR:</strong> Declining population immunity following trivalent OPV withdrawal in Pakistan is documents, and wide heterogeneity in the population impact of supplementary immunization campaigns is documented, emphasizing the importance of immunization campaign coverage for type 2 outbreak response in the final stages of polio eradication.</p>
                <p><strong>Cost:</strong> 0.003</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e13.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e13.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of age-specific poliovirus transmission, immunity, vaccination coverage, and infection patterns in Pakistan, with particular attention to the role of older age groups (older children, adolescents, and adults).</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Type-2 polio serosurvey (Pakistan)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A population-based serological study conducted in Pakistan assessing immunity and field efficacy of type 2-containing polio vaccines following cessation of trivalent oral poliovirus vaccine (tOPV). The paper's metadata indicates it focuses on serologic measurement of type-2 immunity at the population level after programmatic vaccine changes.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_location</strong></td>
                            <td>Pakistan</td>
                        </tr>
                        <tr>
                            <td><strong>study_period</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>population-based serological study</td>
                        </tr>
                        <tr>
                            <td><strong>age_groups_studied</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>sample_size_by_age</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>seroprevalence_by_age</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>vaccination_coverage_by_age</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>case_detection_by_age</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>infection_detection_by_age</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>asymptomatic_infections</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>transmission_patterns</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_surveillance_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>contact_patterns</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>immunity_gaps</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>risk_factors_by_age</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>role_of_older_ages_summary</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparative_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan', 'publication_date_yy_mm': '2020-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <p class="empty-note">No potentially relevant new papers extracted.</p>
        </div>

        </div>

    </div>
</body>
</html>